Quarterly report pursuant to Section 13 or 15(d)

Acquisition (Details Narrative)

v3.22.2.2
Acquisition (Details Narrative)
9 Months Ended
Sep. 30, 2022
USD ($)
shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles $ 1,240,000,000,000
Assumed liabilities 1,000,000
Purchase price 247,000
Transaction costs $ 21,600
Common Stock [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Number of shares issued | shares 52,023
Anti Dilution Shares [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Number of shares issued | shares 344,159
Jantibody Agreement [Member] | Common Stock [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Number of shares issued | shares 52,023